Literature DB >> 33184237

The ZSWIM8 ubiquitin ligase mediates target-directed microRNA degradation.

Charlie Y Shi1,2,3, Elena R Kingston1,2,3, Benjamin Kleaveland4, Daniel H Lin1,2,3, Michael W Stubna1,2,3, David P Bartel5,2,3.   

Abstract

MicroRNAs (miRNAs) associate with Argonaute (AGO) proteins to direct widespread post-transcriptional gene repression. Although association with AGO typically protects miRNAs from nucleases, extensive pairing to some unusual target RNAs can trigger miRNA degradation. Here we found that this target-directed miRNA degradation (TDMD) required the ZSWIM8 Cullin-RING E3 ubiquitin ligase. This and other findings suggested and supported a mechanistic model of TDMD in which target-directed proteolysis of AGO by the ubiquitin-proteasome pathway exposes the miRNA for degradation. Moreover, loss-of-function studies indicated that the ZSWIM8 Cullin-RING ligase accelerates degradation of numerous miRNAs in cells of mammals, flies, and nematodes, thereby specifying the half-lives of most short-lived miRNAs. These results elucidate the mechanism of TDMD and expand its inferred role in shaping miRNA levels in bilaterian animals.
Copyright © 2020, American Association for the Advancement of Science.

Entities:  

Year:  2020        PMID: 33184237     DOI: 10.1126/science.abc9359

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  39 in total

1.  MicroRNA 3'-compensatory pairing occurs through two binding modes, with affinity shaped by nucleotide identity and position.

Authors:  Sean E McGeary; Namita Bisaria; Thy M Pham; Peter Y Wang; David P Bartel
Journal:  Elife       Date:  2022-02-22       Impact factor: 8.140

2.  Terminal modification, sequence, length, and PIWI-protein identity determine piRNA stability.

Authors:  Ildar Gainetdinov; Cansu Colpan; Katharine Cecchini; Amena Arif; Karina Jouravleva; Paul Albosta; Joel Vega-Badillo; Yongjin Lee; Deniz M Özata; Phillip D Zamore
Journal:  Mol Cell       Date:  2021-10-08       Impact factor: 17.970

Review 3.  Learning noncoding RNA biology from viruses.

Authors:  Demián Cazalla
Journal:  Mamm Genome       Date:  2021-09-07       Impact factor: 2.957

4.  LncRNA OIP5-AS1-directed miR-7 degradation promotes MYMX production during human myogenesis.

Authors:  Jen-Hao Yang; Ming-Wen Chang; Dimitrios Tsitsipatis; Xiaoling Yang; Jennifer L Martindale; Rachel Munk; Aiwu Cheng; Elizabeth Izydore; Poonam R Pandey; Yulan Piao; Krystyna Mazan-Mamczarz; Supriyo De; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Nucleic Acids Res       Date:  2022-06-23       Impact factor: 19.160

Review 5.  MicroRNAs in kidney injury and disease.

Authors:  Nassim Mahtal; Olivia Lenoir; Claire Tinel; Dany Anglicheau; Pierre-Louis Tharaux
Journal:  Nat Rev Nephrol       Date:  2022-08-16       Impact factor: 42.439

6.  Ago2 protects Drosophila siRNAs and microRNAs from target-directed degradation, even in the absence of 2'-O-methylation.

Authors:  Elena R Kingston; David P Bartel
Journal:  RNA       Date:  2021-04-14       Impact factor: 4.942

7.  Intercellular transmission of endoplasmic reticulum stress through gap junction targeted by microRNAs as a key step of diabetic kidney diseases?

Authors:  Mitsuo Kato
Journal:  Ann Transl Med       Date:  2021-05

8.  Screening by deep sequencing reveals mediators of microRNA tailing in C. elegans.

Authors:  Karl-Frédéric Vieux; Katherine P Prothro; Leanne H Kelley; Cameron Palmer; Eleanor M Maine; Isana Veksler-Lublinsky; Katherine McJunkin
Journal:  Nucleic Acids Res       Date:  2021-11-08       Impact factor: 16.971

Review 9.  Noncoding RNA crosstalk in brain health and diseases.

Authors:  Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2021-07-16       Impact factor: 4.297

10.  Inhibition of lncRNA SNHG8 plays a protective role in hypoxia-ischemia-reoxygenation-induced myocardial injury by regulating miR-335 and RASA1 expression.

Authors:  Yanfeng Liu; Ping Zhou; Fengxiao Wang; Xuehong Zhang; Dongmei Yang; Lang Hong; Dongyun Ruan
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.